Skip to content

Seaport Therapeutics, Inc.

SPTX· NasdaqCore metricsCIK 2042347

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -5.70%
Market cap
$1.08B
53.53M shares
Filings
59
—
—
—
-$26.39M
Q3 2026
—
-$30.35M
Q3 2026
—
-$69.00M
Q3 2026derived
—
-$0.49
Q3 2026
—
$61.55M
Q3 2026
—
$1.08B
—
—
2.7×
—
—

FY2026 figures · derived

Price

$20.10+1.31%+$0.26since May 1, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$23.89MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Seaport Therapeutics, Inc. is the 142nd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Seaport Therapeutics, Inc. · CIK 2042347 · Engraved from SEC EDGAR